News
Health Canada announces plans to tackle drug shortages
2014-01-28 Health Canada announced on 13 September 2013 plans, which it is hoped will help to address problems the country has been having with shortages of… Read More »
Use of generic anti-asthmatic drugs in Morocco
2014-01-23 Asthma is a serious public health problem in Morocco. However, due to low income and lack of healthcare coverage in the country many of Morocco’s… Read More »
UK biosimilars uptake lower than in some other EU countries
2014-01-21 Use of biosimilars in the UK is lower than might be expected when looking at the use of generics in the UK, and it is… Read More »
Challenges and opportunities for anticancer mAbs
2014-01-16 Several best-selling monocloncal antibodies (mAbs) are due to lose patent protection; presenting regulatory authorities with a complex set of challenges as they prepare for the… Read More »
India’s pharma moving from generics to niche drugs
2014-01-14 Indian pharmaceutical companies will increasingly move away from the overcrowded and competitive area of generics and invest more R & D spending in niche drugs,… Read More »
South Africa introduces new patent policy
2014-01-09 South Africa has become the latest country to examine its patent laws with a view to curbing patent evergreening and increasing production of generics. The… Read More »
Therapeutic substitution could save Americans money
2014-01-07 Substituting more expensive brand-name drugs with generics or therapeutic substitutes, could lead to significant savings for Medicare Part D beneficiaries, according to US researchers. Researchers… Read More »
Implications of the changes in venlafaxine utilization in Sweden following generics
2014-01-02 Godman and co-authors review the changes in the utilization of venlafaxine post generics. This includes the limited influence on utilization post generics with no specific… Read More »
Assessment of efficacy and safety of biosimilars in rheumatology
2013-12-31 During the last decade, the availability of biological therapies has revolutionized the treatment of rheumatoid arthritis. Biologicals, unlike small-molecule chemical drugs, are extremely complex molecules,… Read More »
How to avoid drug shortages
2013-12-26 Despite FDA having made progress in recent years to combat drug shortages, the issue is still a major problem for the agency. This very fact… Read More »
